All In MedTech

Device Trial Radar · NCT07592702

AI-Integrated 3D-Printed Videolaryngoscope for Orotracheal Intubation in Critically Ill Patients

Clinical Performance and Usability of an AI Integrated 3D-Printed Videolaryngoscope for Orotracheal Intubation in Critically Ill Patients

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Mar 20, 2027

Primary completion

Dec 2027

Study completion Jun 2028

Sponsor

Lead sponsor
Federal University of PelotasAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Universidade Federal de Santa Catarina; Universidade Católica de Pelotas; Universidade Federal do Rio Grande (FURG)
First posted
May 18, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Background: Orotracheal intubation is an essential procedure in critically ill patients requiring ventilatory support, and the use of videolaryngoscopy is recommended as the gold standard in clinical practice. In recent years, the development of videolaryngoscopes through additive manufacturing has demonstrated lower production costs, and their integration with artificial intelligence (AI) has shown promising results in improving procedural success and safety. Aim: To evaluate the clinical performance and usability of a videolaryngoscope developed through additive manufacturing and integrated with artificial intelligence (AI) and computer vision, compared with a commercially available gold-standard videolaryngoscope. Methods: This is a multicenter, randomized, controlled, superiority Phase I/II clinical trial with a single-blind design. A total of 120 critically ill patients admitted to intensive care units at four hospitals in southern Brazil will be enrolled. Participants will be individually randomized in a 1:1 allocation ratio to parallel groups. The interventions will be performed by at least 10 physicians. All physicians will receive standardized training on device use, and procedures will be monitored by trained research staff. Data will be recorded in electronic Excel spreadsheets, and statistical analyses will be conducted using IBM SPSS Statistics. All ethical principles will be strictly observed, including obtaining informed consent from participants or their legal representatives. A Data and Safety Monitoring Committee will be established to oversee the study. Conclusions: If the expected results are confirmed, patients, healthcare professionals, and healthcare institutions may benefit from the improved performance, safety, and usability of the experimental device, particularly in critical care settings and public health emergencies.

Conditions

  • Orotracheal Intubation

Interventions

  • Orotracheal intubation using a 3D videolaryngoscope integrated with artificial intelligence (VL-IA).Device

    The videolaryngoscope (VL) incorporates a microcamera at the tip of the blade, enabling real-time visualization of anatomical structures via a monitor. The VL to be used in the intervention was manufactured through additive manufacturing using polylactic acid (PLA) and polyethylene terephthalate glycol (PETG). It was validated in high-fidelity simulations for mechanical strength and usability and is patented under number BR 10 2020 026194 with the Brazilian National Institute of Industrial Property (INPI). The VL is currently being enhanced through the integration of artificial intelligence (AI) using computer vision techniques based on Machine Learning and Deep Learning, including convolutional neural networks capable of automatically recognizing upper airway anatomical structures from previously trained image datasets. The embedded system will provide real-time visual and audio guidance during intubation with less than one-second latency.

  • Commercially available gold-standard videolaryngoscope (VL-C)Device

    Scientific evidence recommends the use of VL in all cases of intubation, across various clinical scenarios, as the primary intubation technique in clinical practice. The videolaryngoscope incorporates a microcamera at the tip of the blade, allowing visualization of anatomical structures in real time via a monitor.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Correct glottis visualization rate (%)Time frame: immediately after insertion of the videolaryngoscope
  2. First-attempt intubation success rate (%)Time frame: immediately after the first intubation
  3. Number of attempts required for successful intubation (n)Time frame: immediately after a successful intubation

1 more outcomes with a free account

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Husfp - Ucpel

    Pelotas, Rio Grande do Sul, Brazil

  • Ebserh/Ufpel

    Pelotas, Rio Grande do Sul, Brazil

  • Ebserh/Furg

    Rio Grande, Rio Grande do Sul, Brazil

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.